A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients
Alessandro Viganò(Sapienza University of Rome), Vittorio Di Piero(Sapienza University of Rome), Rita De Sanctis(Humanitas University), Ilaria Maestrini(Sapienza University of Rome), Ersilia Savastano(Sapienza University of Rome), Barbara Petolicchio(Policlinico Umberto I), Massimiliano Toscano(Fatebenefratelli Hospital)
Cited by 21
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
|European Journal of Nuclear Medicine and Molecular Imaging|2019|150